Fred Hutch research assistant Jeremy Hollis wins 2025 Harold M. Weintraub Graduate Student Award. The longstanding award ...

Fred Hutch is integrating a new artificial intelligence (AI) technology, GI Genius, into colonoscopy scans to help evaluate ...

New treatments for graft-vs.-host disease, updated dosage for HPV vaccines — and Fred Hutch announces awards for graduate students.

SEATTLE — March 4, 2025 — Fred Hutch Cancer Center announced 10 recipients of the annual Harold M. Weintraub Graduate Student Award, which recognizes the exceptional achievements of graduate studies ...

Researchers at Fred Hutch Cancer Center have discovered an overlooked mechanism driving aggressive breast and brain tumors ...

What's new in proton therapy? Read the latest news and views from Fred Hutch's proton therapy facility’s patients and providers in The Beam, published monthly.

Robert Redman has had many treatments for brain and spinal cord cancer in the past 17 years, including proton, gamma and ...

Fred Hutch Cancer Center is inviting applications for innovative projects to address and improve multiple social determinants of health among under represented communities in Washington State, ...

Dr. Eddie Méndez was a physician-scientist and cherished colleague at Fred Hutch who died of cancer in 2018 at age 45. An expert in head and neck cancers, Méndez was known for being passionate about ...

As we near the five-year mark since the start of the COVID-19 pandemic, the healthcare community is still wrestling with the psychological fallout of being on the frontlines of a global crisis. The ...

Although you’re probably not a virologist, chances are you know a thing or two about herpes simplex virus (HSV), which is estimated to infect roughly two-thirds of the world’s population and causes ...

Chronic graft-vs.-host disease (cGVHD) can be debilitating for people who have had an allogeneic stem cell transplant. In GVHD, the transplanted donor cells recognize the recipient’s tissues as ...